Marketed By
Admac life science
Pack of
1 vial(s) of 5ml
Salt Composition
Fulvestrant
Storage
keep store in cold place
Contact for Price
Fulvimac 250mg Injection
Delivering To: —
Description
Fulvimac 250mg Injection is used to treat hormone receptor-positive breast cancer in postmenopausal women.It is strictly given under medical supervision.
Fulvimac 250mg Injection contains fulvestrant acts as a selective estrogen receptor degrader (SERD) that inhibits cancer cell growth and proliferation.
Uses
- HR+ Breast Cancer
Side Effects
Fulvimac 250mg Injection is a chemical salt based anticancer medication.Therefore,it has several common side effects like any other medicine.Consult your doctor, if side effects persist for longer period of time.
- Hot flashes
- Nausea
- Vomiting
- Muscle cramps
- Abdominal pain
- Diarrhea
- Skin rashes
- Weakness
- Dizziness
- Edema
- Weight changes
- Headache
- Osteoporosis
- Fatigue
- Mood changes
- Stomach bleeding
- Severe skin reactions
- Blood disorders
- Cardiovascular Problems
How To Use
- Fulvimac 250mg Injection is taken intramuscular, into the buttock muscle from a doctor or an experienced nurse.
- Do not self administer the injection. Follow the doctor's prescribed dosage and time.
How It Works
- Fulvimac 250mg Injection (fulvestrant) acts as a selective estrogen receptor degrader (SERD).
- Fulvestrant binds competitively to estrogen receptors (ER) with affinity similar to estradiol, preventing dimerization, nuclear translocation, and DNA binding, while accelerating ER protein degradation via the proteasome pathway.
Safety Advice
Alcohol
UNSAFE
Pregnancy
CONSULT YOUR DOCTOR
Breast Feeding
CONSULT YOUR DOCTOR
Driving
DANGER
Kidney
PRECAUTION
Liver
PRECAUTION
FAQs
Fulvimac 250mg Injection cause harm to growing fetus as well as is teratogenic in nature. Thus, it is not recommended during pregnancy for treatment.
Yes, Fulvimac 250mg Injection can be given with other chemotherapeutic drugs. Consult your doctor for drug interaction knowledge and personalized guidance.
Take Fulvimac 250mg Injection as soon as you remember it unless it is the time for the next dose. Do not double the dosage. Also inform your doctor about the missed dose.
Fulvimac 250mg Injection is taken intramuscular, into the buttock muscle from a doctor or an experienced nurse. Do not self administer the injection. Follow the doctor's prescribed dosage and time.
Fulvimac 250mg Injection is used to treat hormone receptor-positive breast cancer in postmenopausal women.
References
- Osborne, C. K., Wakeling, A., & Nicholson, R. I. (2004). Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. British journal of cancer, 90(1), S2-S6. https://pubmed.ncbi.nlm.nih.gov/15094757/
- Curran, M., & Wiseman, L. (2001). Fulvestrant. Drugs, 61(6), 807-813. https://pubmed.ncbi.nlm.nih.gov/11398912/
- Wardley, A. M. (2002). FULVESTRANT: A REVIEW OF ITS DEVELOPMENT, PRE‐CLINICAL AND CLINICAL DATA. International journal of clinical practice, 56(4), 305-309.
- Johnston, S. J., & Cheung, K. L. (2010). Fulvestrant-a novel endocrine therapy for breast cancer. Current medicinal chemistry, 17(10), 902-914.
Ratings And Reviews
4.67/5
3 Ratings
5 Star
66.67%
4 Star
33.33%
3 Star
0.00%
2 Star
0.00%
1 Star
0.00%
Harsh Joshi
Trustworthy brand
a year ago
William Taylor
Impressed with the quality
a year ago
View All Reviews
Related Products
MARKETER DETAILS
Admac life science
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.